J Clin Invest (1992) 90(4):13237
published in Clinical Nutrition found that when patients with type 1 diabetes consumed a meal containing EVOO, their postprandial GLP-1 response was significantly higher than when the same meal was consumed with butter or very little fat (Bozzetto et al., 2019)
PKF275-055, an analogue of vildagliptin and a DPP-4 inhibitor, counteracted changes in Na/K-ATPase activity, nerve conduction velocity, and nociceptive thresholds in diabetic rats [50]
More information about NovoCare Pharmacy is available at NovoCare.com
If you want to start doctor-supervised peptide therapy, you can contact us.
The article says patients with a history of medullary thyroid cancer, severe pancreatitis, or multiple endocrine neoplasia type 2 should avoid both medications and consult their provider